Journal ID (nlm-ta): Eur Heart J
Journal ID (iso-abbrev): Eur Heart J
Journal ID (publisher-id): eurheartj
Title:
European Heart Journal
Publisher:
Oxford University Press
(US
)
ISSN
(Print):
0195-668X
ISSN
(Electronic):
1522-9645
Publication date Collection: 14
November
2022
Publication date
(Electronic):
15
September
2022
Publication date PMC-release: 15
September
2022
Volume: 43
Issue: 43
,
Focus Issue on Vascular Biology and Medicine
Pages: 4548-4561
Affiliations
King’s College London, British Heart Foundation Centre of Research Excellence, School
of Cardiovascular and Metabolic Medicine and Sciences , The James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK
King’s College London, British Heart Foundation Centre of Research Excellence, School
of Cardiovascular and Metabolic Medicine and Sciences , The James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK
Author notes
Conflicts of interest: A.M.S. is an adviser to Forcefield Therapeutics and CYTE—Global Network for Clinical
Research and sits on the Board of Heqet Therapeutics. M.G. is founder, consultant,
member of the board, and equity holder in Purespring Therapeutics, Forcefield Therapeutics,
and Heqet Therapeutics, and is a member of the Scientific Advisory Boards of Trizell
Holding SA and DINAQR AG.
Author information
Article
Publisher ID:
ehac463
DOI: 10.1093/eurheartj/ehac463
PMC ID: 9659475
PubMed ID: 36106499
SO-VID: 726c6ee7-0590-4a93-9aff-f7e4e25bb413
Copyright © © The Author(s) 2022. Published by Oxford University Press on behalf of European Society
of Cardiology.
License:
This is an Open Access article distributed under the terms of the Creative Commons
Attribution-NonCommercial License (
https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
Funded by:
British Heart Foundation, doi 10.13039/501100000274;
Award ID: CH/1999001/11735, RE/18/2/34213, RM/17/3/33381
Funded by:
Fondation Leducq, doi 10.13039/501100001674;
Award ID: 17CVD04
Funded by:
European Research Council, doi 10.13039/501100000781;
Award ID: 787971
Funded by:
British Heart Foundation, doi 10.13039/501100000274;
Award ID: RG/19/11/34633
Funded by:
European Commission Horizon;
Award ID: 825670
Award ID: 874764
Funded by:
National Institute for Health Research Biomedical Research Centre at Guy’s;
Funded by:
Thomas’ NHS Foundation Trust with King’s College London;
Award ID: IS-BRC-543 1215-20006
Subject:
State of the Art Review
Subject:
Heart Failure and Cardiomyopathies
Subject:
AcademicSubjects/MED00200
Subject:
Eurheartj/27
Subject:
Eurheartj/29
Subject:
Eurheartj/14